Pediatric Disease Registry in Essential Thrombocythaemia (ET)

The aim of this study is to evaluate the progression of ET in children (aged 6-17years inclusive) over a period of 5 years maximum. The study will also assess how children are diagnosed, treatment options for those children with symptoms and events related to their ET and the outcomes of those treatments.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Essential Thrombocythemia (ET) Blood Coagulation Disorders Blood Platelet Disorders Bone Marrow Diseases Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhagic Disorders Myeloproliferative Disorders Thrombocythemia, Essential Thrombocytosis

Age range

6 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Paediatric Clinic University Hospital Olomouc, Olomouc, Czechia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

6 years or over and less than 18 years patient has ET according to the WHO criteria as guidance

Exclusion criteria

Interventional clinical study participation

Treatment and study plan

Primary outcomes

Treatment effects on platelet count in children ages 6-17 years inclusive.

Time frame: 60 months

Secondary outcomes

Drug utilization of cytoreductive therapy in children ages 6-17 years inclusive

Time frame: 60 months

Sponsors and collaborators

Lead sponsor

Shire

Industry

Registry information

Official study title

Multicentre Paediatric Disease Registry in Essential Thrombocythaemia

Important dates

Study start: 2010
Primary completion: 2016
Study completion: 2016
First posted: Sep 10, 2010
Registry last updated: Mar 17, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed